Glutathione peroxidase 7 has potential tumour suppressor functions that are silenced by location-specific methylation in oesophageal adenocarcinoma

Gut

Volumn 63, Issue 4, 2014, Pages 540-551

  Peng, Dunfa ^a,b   Hu, Tianling ^a,b   Soutto, Mohammed ^a,b   Belkhiri, Abbes ^b   Zaika, Alexander ^b   El Rifai, Wael ^a,b  

^a DEPARTMENT OF VETERANS AFFAIRS   (United States)

^b VANDERBILT INGRAM CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GLUTATHIONE PEROXIDASE; GLUTATHIONE PEROXIDASE 7; PROTEIN P16; PROTEIN P21; PROTEIN P27; PROTEIN P73; RETINOBLASTOMA PROTEIN; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BIOLOGICAL FUNCTIONS; CARCINOMA CELL; CELL AGING; CELL CYCLE G1 PHASE; CELL CYCLE PROGRESSION; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COLONY FORMATION; CONTROLLED STUDY; DNA METHYLATION; DOWN REGULATION; ESOPHAGEAL ADENOCARCINOMA; EXON; GENE DOSAGE; GENE OVEREXPRESSION; GENE SILENCING; GROWTH CURVE; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PYROSEQUENCING; TUMOR XENOGRAFT; WESTERN BLOTTING;

CANCER; CELL CYCLE; GASTROINTESTINAL CANCER; OESOPHAGEAL CANCER;

ADENOCARCINOMA; ANIMALS; CELL CYCLE; CELL LINE, TUMOR; CELL PROLIFERATION; DNA METHYLATION; DNA, NEOPLASM; ESOPHAGEAL NEOPLASMS; GENE EXPRESSION REGULATION, NEOPLASTIC; GENE SILENCING; HUMANS; MICE; MICE, NUDE; NEOPLASM TRANSPLANTATION; PEROXIDASES; TUMOR SUPPRESSOR PROTEINS;

EID: 84895466271     PISSN: 00175749     EISSN: 14683288     Source Type: Journal    
DOI: 10.1136/gutjnl-2013-304612     Document Type: Article

References (45)

1. Parkin DM, Pisani P, Ferlay J. Global cancer statistics. CACancer J Clin 1999;49:33-64, 1. (Pubitemid 29094960)
2. Spechler SJ, Goyal RK. Barrett's esophagus. N Engl J Med 1986;315:362-71. (Pubitemid 16060091)
3. Musana AK, Resnick JM, Torbey CF, et al. Barrett's esophagus: incidence and prevalence estimates in a rural Mid-Western population. Am J Gastroenterol 2008;103:516-24. (Pubitemid 351405967)
4. Gilbert EW, Luna RA, Harrison VL, et al. Barrett's esophagus: a review of the literature. J Gastrointest Surg 2011;15:708-18.
5. Drewitz DJ, Sampliner RE, Garewal HS. The incidence of adenocarcinoma in Barrett's esophagus: a prospective study of 170 patients followed 4.8 years. Am J Gastroenterol 1997;92:212-15. (Pubitemid 27076463)
6. Shaheen NJ, Richter JE. Barrett's oesophagus. Lancet 2009;373:850-61.
7. Brigelius-Flohe R. Glutathione peroxidases and redox-regulated transcription factors. Biol Chem 2006;387:1329-35. (Pubitemid 44691411)
8. Brigelius-Flohe R, Kipp A. Glutathione peroxidases in different stages of carcinogenesis. Biochim Biophys Acta 2009;1790:1555-68.
9. Utomo A, Jiang X, Furuta S, et al. Identification of a novel putative non-selenocysteine containing phospholipid hydroperoxide glutathione peroxidase (NPGPx) essential for alleviating oxidative stress generated from polyunsaturated fatty acids in breast cancer cells. J Biol Chem 2004;279:43522-9. (Pubitemid 39390652)
10. Peng D, Belkhiri A, Hu T, et al. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut 2012;61:1250-60.
11. Peng DF, Razvi M, Chen H, et al. DNA hypermethylation regulates the expression of members of the Mu-class glutathione S-transferases and glutathione peroxidases in Barrett's adenocarcinoma. Gut 2009;58:5-15.
12. Siewert JR, Feith M, Stein HJ. Biologic and clinical variations of adenocarcinoma at the esophago-gastric junction: relevance of a topographic-anatomic subclassification. J Surg Oncol 2005;90:139-46; discussion 146. (Pubitemid 40741176)
13. Peng D, Belkhiri A, Hu T, et al. Glutathione peroxidase 7 protects against oxidative DNA damage in oesophageal cells. Gut 2012;61:1250-60.
14. Ochi N, Tanasanvimon S, Matsuo Y, et al. Protein kinase D1 promotes anchorage-independent growth, invasion and angiogenesis by human pancreatic cancer cells. J Cell Physiol 2011;226:1074-81.
15. Vangamudi B, Peng DF, Cai Q, et al. t-DARPP regulates phosphatidylinositol-3-kinase-dependent cell growth in breast cancer. Mol Cancer 2010;9:240.
16. Ma HT, Poon RY. Synchronization of HeLa cells. Methods Mol Biol 2011;761:151-61.
17. Soutto M, Peng D, Razvi M, et al. Epigenetic and genetic silencing of CHFR in esophageal adenocarcinomas. Cancer 2010;116:4033-42.
18. Peng D, Hu TL, Jiang A, et al. Location-specific epigenetic regulation of the metallothionein 3 gene in esophageal adenocarcinomas. PLoS One 2011;6:e22009.
19. Jain S, Chen S, Chang KC, et al. Impact of the location of CpG methylation within the GSTP1 gene on its specificity as a DNA marker for hepatocellular carcinoma. PLoS One 2012;7:e35789.
20. van Vlodrop IJ, Niessen HE, Derks S, et al. Analysis of promoter CpG island hypermethylation in cancer: location, location, location!. Clin Cancer Res 2011;17:4225-31.
21. Sandhu C, Slingerland J. Deregulation of the cell cycle in cancer. Cancer Detect Prev 2000;24:107-18. (Pubitemid 30427696)
22. Vermeulen K, Van Bockstaele DR, Berneman ZN. The cell cycle: a review of regulation, deregulation and therapeutic targets in cancer. Cell Prolif 2003;36:131-49. (Pubitemid 36808270)
23. Merola E, Mattioli E, Minimo C, et al. Immunohistochemical evaluation of pRb2/p130, VEGF, EZH2, p53, p16, p21waf-1, p27 and PCNA in Barrett's esophagus. J Cell Physiol 2006;207:512-19.
24. Spechler SJ. Barrett's esophagus: a molecular perspective. Curr GastroenterolRep 2005;7:177-81. (Pubitemid 40916396)
25. Bian YS, Osterheld MC, Fontolliet C, et al. p16 inactivation by methylation of the CDKN2A promoter occurs early during neoplastic progression in Barrett's esophagus. Gastroenterology 2002;122:1113-21. (Pubitemid 34267292)
26. Wong DJ, Paulson TG, Prevo LJ, et al. p16 (INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001;61:8284-9. (Pubitemid 33091623)
27. Liggett WH Jr, Sidransky D. Role of the p16 tumor suppressor gene in cancer. J Clin Oncol 1998;16:1197-206. (Pubitemid 28108758)
28. Roussel MF. The INK4 family of cell cycle inhibitors in cancer. Oncogene 1999;18:5311-17. (Pubitemid 29462366)
29. Lee J, Kim SS. The function of p27 KIP1 during tumor development. Exp Mol Med 2009;41:765-71.
30. Sicinski P, Zacharek S, Kim C. Duality of p27Kip1 function in tumorigenesis. Genes Dev 2007;21:1703-6.
31. Abukhdeir AM. Park BH, P21 and p27: roles in carcinogenesis and drug resistance. Expert Rev Mol Med 2008;10:e19.
32. McChesney PA, Aiyar SE, Lee OJ, et al. Cofactor of BRCA1: a novel transcription factor regulator in upper gastrointestinal adenocarcinomas. Cancer Res 2006;66:1346-53. (Pubitemid 43259913)
33. Boonstra JJ, van Marion R, Beer DG, et al. Verification and unmasking of widely used human esophageal adenocarcinoma cell lines. J Natl Cancer Inst 2010;102:271-4.
34. Zawacka-Pankau J, Kostecka A, Sznarkowska A, et al. p73 tumor suppressor protein: a close relative of p53 not only in structure but also in anti-cancer approach? Cell Cycle 2010;9:720-8.
35. Flores ER, Sengupta S, Miller JB, et al. Tumor predisposition in mice mutant for p63 and p73: evidence for broader tumor suppressor functions for the p53 family. Cancer cell 2005;7:363-73. (Pubitemid 40544653)
36. Shay JW, Roninson IB. Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 2004;23:2919-33. (Pubitemid 38638853)
37. Collado M, Blasco MA, Serrano M. Cellular senescence in cancer and aging. Cell 2007;130:223-33. (Pubitemid 47081143)
38. Rayess H, Wang MB, Srivatsan ES, Cellular senescence and tumor suppressor gene p16. International journal of cancer. Int J Ccancer 2012;130:1715-25.
39. Lee OJ, Schneider-Stock R, McChesney PA, et al. Hypermethylation and loss of expression of glutathione peroxidase-3 in Barrett's tumorigenesis. Neoplasia 2005;7:854-61.
40. Esteller M, Fraga MF, Paz MF, et al. Cancer epigenetics and methylation. Science 2002;297:1807-8; discussion 1807-8.
41. Jones PA. DNA methylation and cancer. Oncogene 2002;21:5358-60. (Pubitemid 34983472)
42. Herman JG, Baylin SB. Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 2003;349:2042-54. (Pubitemid 37448928)
43. Tamura G. Alterations of tumor suppressor and tumor-related genes in the development and progression of gastric cancer. World J Gastroenterol: WJG 2006;12:192-8. (Pubitemid 43336916)
44. Jarrard DF, Bova GS, Ewing CM, et al. Deletional, mutational and methylation analyses of CDKN2 (p16/MTS1) in primary and metastatic prostate cancer. Genes Chromosomes Cancer 1997;19:90-6. (Pubitemid 27231483)
45. Knudson AG. Two genetic hits (more or less) to cancer. Nat Rev Cancer 2001;1:157-62. (Pubitemid 33741891)